Results 131 to 140 of about 126,067 (267)

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

, 2011
Description: This guideline is an official statement of the American College of Physicians (ACP), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), and European Respiratory Society (ERS).
Hanania, Nicola A., Weinberger, Steven E., Wilt, Timothy J., Criner, Gerard, van der Molen, Thys, Marciniuk, Darcy D., Schuenemann, Holger, Wedzicha, Wisia, MacDonald, Roderick, Qaseem, Amir, Shekelle, Paul, Denberg, Tom   +11 more
core   +1 more source

Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation

Psychiatry and Clinical Neurosciences, EarlyView.
Aim Vesicular monoamine transporter 2 (VMAT2) inhibitors have been approved for the treatment of tardive dyskinesia (TD), whereas anticholinergic agents are still widely used for this condition. This study aimed to compare the risk of major clinical adverse outcomes among patients with TD treated with VMAT2 inhibitors versus anticholinergic agents ...
Tien‐Wei Hsu, Chih‐Wei Hsu, Ping‐Tao Tseng, Yi‐Ya Fang, Chuo‐Yu Lee, Yu‐Hsuan Lin, Brendon Stubbs, Trevor Thompson, Andre F. Carvalho, Yu‐Chen Kao, Jen‐Ping Chen, Fu‐Chi Yang, Chia‐Kuang Tsai, Chih‐Sung Liang   +13 more
wiley   +1 more source

Frequency and correlates of anticholinergic use among patients with schizophrenia in Denmark:A Nation-wide pharmacoepidemiological study

, 2017
Anticholinergic medications are used to treat extrapyramidal adverse effects induced by antipsychotics. Anticholinergics are associated with adverse effects: constipation, dry mouth and worsening of cognitive function. Anticholinergics have potential for
S.G. Pristed, Pristed, S G, C.U. Correll, Correll, C U, Nielsen, Jimmi, J. Nielsen   +5 more
core   +1 more source

Women in space: A review of known physiological adaptations and health perspectives

Experimental Physiology, EarlyView.
Abstract Exposure to the spaceflight environment causes adaptations in most human physiological systems, many of which are thought to affect women differently from men. Since only 11.5% of astronauts worldwide have been female, these issues are largely understudied.
Millie Hughes‐Fulford, Danielle J. Carroll, Heather C. M. Allaway, Bonnie J. Dunbar, Aenor J. Sawyer   +4 more
wiley   +1 more source

ПАТОГЕНЕТИЧЕСКИЕ ОСНОВЫ ХОЛИНОЛИТИЧЕСКОЙ ТЕРАПИИ И ВОЗМОЖНЫЕ МЕХАНИЗМЫ ЕЕ ПОТЕНЦИРОВАНИЯ ПОД ВЛИЯНИЕМ β2-АДРЕНОМИМЕТИКОВ

, 2014
Current basic therapy of chronic obstructive pulmonary disease includes inhaled long-acting bronchodilators. This article reviews mechanisms of action of anticholinergic drugs and their potentiation with beta-2-agonists.
V. I. Trofimov, В. И. Трофимов, Л. Н. Сорокина, L. N. Sorokina   +3 more
core   +1 more source

The Blue Delirium: Serotonin and Anticholinergic Toxicity in a 95‐Year‐Old Woman

Journal of the American Geriatrics Society, EarlyView.
Camila S. Badell, Kathleen Brodowski, Eloy F. Ruiz, Eric Tien Yen Chyn   +3 more
wiley   +1 more source

Intestinal epithelial injury and inflammation after physical work in temperate and hot environments in older men with hypertension or type 2 diabetes

Experimental Physiology, EarlyView.
Abstract We tested whether older adults with well‐controlled type 2 diabetes or hypertension, compared with age‐matched adults without chronic disease, exhibit greater intestinal damage, microbial translocation and inflammation during exertional heat stress.
Ben J. Lee, Tessa R. Flood, Sophie L. Russell, James J. McCormick, Kelli E. King, Naoto Fujii, Tatsuro Amano, Sean Notley, Glen P. Kenny   +8 more
wiley   +1 more source

Effect of add-on therapy of tiotropium in COPD treated with theophylline

International Journal of COPD, 2008
Tomotaka Kawayama1, Tomoaki Hoshino1, Masao Ichiki2, Toru Tsuda3, Masaharu Kinoshita4, Shohei Takata5, Takeharu Koga1, Tomoaki Iwanaga1, Hisamichi Aizawa1, Kurume COPD Study Group*1Department of Medicine, Kurume University School of Medicine, Kurume ...
Tomotaka Kawayama, Tomoaki Hoshino, Masao Ichiki, Toru Tsuda, Masaharu Kinoshita, et al   +5 more
doaj  

Inhaled muscarinic acethylcholine receptor antagonists for treatment of COPD

, 2013
Bronchodilators, generally administered via metered dose or dry powder inhalers, are the mainstays of pharmacological treatment of stable COPD. Inhaled long-acting beta-agonists (LABA) and anticholinergics are the bronchodilators primarily used in the ...
Fuso, Leonello, Montuschi, Paolo, Valente, Salvatore, Macagno, Francesco   +3 more
core   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5767-5778, July 2026.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Peter Ueda, Björn Pasternak   +10 more
wiley   +1 more source